IOBT Accounts Payable vs Total Assets Analysis
| IOBT Stock | USD 0.71 0.03 4.41% |
IO Biotech financial indicator trend analysis is infinitely more than just investigating IO Biotech recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IO Biotech is a good investment. Please check the relationship between IO Biotech Accounts Payable and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IO Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.
Accounts Payable vs Total Assets
Accounts Payable vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IO Biotech Accounts Payable account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between IO Biotech's Accounts Payable and Total Assets is 0.97. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Assets in the same time period over historical financial statements of IO Biotech, assuming nothing else is changed. The correlation between historical values of IO Biotech's Accounts Payable and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of IO Biotech are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Accounts Payable i.e., IO Biotech's Accounts Payable and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.97 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Accounts Payable
An accounting item on the balance sheet that represents IO Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of IO Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Assets
Total assets refers to the total amount of IO Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in IO Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from IO Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IO Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IO Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.At this time, IO Biotech's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.68 in 2024, despite the fact that Enterprise Value is likely to grow to (80.3 M).
IO Biotech fundamental ratios Correlations
Click cells to compare fundamentals
IO Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.